IL193481A0 - 4-phenyl-thiazole-5-carboxylic acids and 4 - phenyl - thiazole - 5 - carboxylic acid amides as plk1 inhibitors - Google Patents

4-phenyl-thiazole-5-carboxylic acids and 4 - phenyl - thiazole - 5 - carboxylic acid amides as plk1 inhibitors

Info

Publication number
IL193481A0
IL193481A0 IL193481A IL19348108A IL193481A0 IL 193481 A0 IL193481 A0 IL 193481A0 IL 193481 A IL193481 A IL 193481A IL 19348108 A IL19348108 A IL 19348108A IL 193481 A0 IL193481 A0 IL 193481A0
Authority
IL
Israel
Prior art keywords
thiazole
phenyl
acid amides
carboxylic acid
carboxylic acids
Prior art date
Application number
IL193481A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL193481A0 publication Critical patent/IL193481A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL193481A 2006-02-27 2008-08-14 4-phenyl-thiazole-5-carboxylic acids and 4 - phenyl - thiazole - 5 - carboxylic acid amides as plk1 inhibitors IL193481A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27
PCT/EP2007/051541 WO2007096315A1 (en) 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors

Publications (1)

Publication Number Publication Date
IL193481A0 true IL193481A0 (en) 2009-05-04

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193481A IL193481A0 (en) 2006-02-27 2008-08-14 4-phenyl-thiazole-5-carboxylic acids and 4 - phenyl - thiazole - 5 - carboxylic acid amides as plk1 inhibitors

Country Status (19)

Country Link
US (1) US7504513B2 (OSRAM)
EP (1) EP1991543A1 (OSRAM)
JP (1) JP2009528284A (OSRAM)
KR (1) KR101060539B1 (OSRAM)
CN (1) CN101415704A (OSRAM)
AR (1) AR059621A1 (OSRAM)
AU (1) AU2007217575A1 (OSRAM)
BR (1) BRPI0710473A2 (OSRAM)
CA (1) CA2642921A1 (OSRAM)
CR (1) CR10206A (OSRAM)
EC (1) ECSP088700A (OSRAM)
IL (1) IL193481A0 (OSRAM)
MA (1) MA30260B1 (OSRAM)
MX (1) MX2008010884A (OSRAM)
NO (1) NO20083708L (OSRAM)
RU (1) RU2008138163A (OSRAM)
TW (1) TW200745097A (OSRAM)
WO (1) WO2007096315A1 (OSRAM)
ZA (1) ZA200807074B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5246158B2 (ja) * 2007-06-08 2013-07-24 日本電気株式会社 半導体集積回路及びフィルタ制御方法
EP2250160B1 (en) 2008-01-25 2015-11-11 Millennium Pharmaceuticals, Inc. Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
CA2721722C (en) * 2008-04-17 2015-12-08 The Johns Hopkins University On01910.na enhances chemotherapeutic agent activity in drug-resistant tumors
CN102150210B (zh) * 2008-09-10 2013-04-10 数据激光有限公司 数据存储介质
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
EP2379543A2 (en) * 2008-12-18 2011-10-26 F. Hoffmann-La Roche AG Thiazolyl-benzimidazoles
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US9062038B2 (en) 2010-08-11 2015-06-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
UY33554A (es) 2010-08-11 2012-02-29 Millennium Pharm Inc Heteroarilos y usos de los mismos
WO2012021615A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
BR112013009166A2 (pt) 2010-10-13 2016-07-26 Millennium Pharm Inc heteroarilas e uso das mesmas.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
CN102060857A (zh) 2000-08-10 2011-05-18 辉瑞意大利有限公司 具有激酶抑制剂活性的二环吡唑类、其制备方法和包含它们的药物组合物
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
US20050107316A1 (en) 2002-02-22 2005-05-19 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
MXPA04008356A (es) 2002-02-28 2005-09-12 Univ Temple (e)-2,6-dialcoxiestiril bencilsulfonas sustituidas con un grupo amino y en la posicion 4 para tratar trastornos poliferativos.
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
US7183276B2 (en) * 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
BR0309758A (pt) 2002-05-03 2005-02-15 Schering Ag Tiazolidinonas e seu uso como inibidortes de cinase semelhante a polo
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
BR0313160A (pt) 2002-08-08 2005-07-12 Smithkline Beecham Corp Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
AU2003290883A1 (en) 2002-11-14 2004-06-15 Lewis C. Cantley Products and processes for modulating peptide-peptide binding domain interactions
JPWO2004043936A1 (ja) 2002-11-14 2006-03-09 協和醗酵工業株式会社 Ｐｌｋ阻害剤
JP3837670B2 (ja) 2002-12-12 2006-10-25 富士通株式会社 データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
WO2004074244A2 (en) 2003-02-20 2004-09-02 Smithkline Beecham Corporation Pyrimidine compounds
JP2006522127A (ja) 2003-04-01 2006-09-28 スミスクライン ビーチャム コーポレーション イミダゾトリアジン化合物
SG161745A1 (en) 2003-06-24 2010-06-29 Pfizer Prod Inc Processes for the preparation of 1-[(benzoimidazole-1 yl) quinolin-8-yl] piperidin-4-ylamine derivatives
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
JP5164380B2 (ja) 2003-10-21 2013-03-21 サイクラセル リミテッド ピリミジン−４−イル−３，４−チオン化合物及び治療におけるその使用
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
US7560568B2 (en) 2004-01-28 2009-07-14 Smithkline Beecham Corporation Thiazole compounds

Also Published As

Publication number Publication date
ZA200807074B (en) 2009-10-28
US7504513B2 (en) 2009-03-17
CN101415704A (zh) 2009-04-22
EP1991543A1 (en) 2008-11-19
MA30260B1 (fr) 2009-03-02
JP2009528284A (ja) 2009-08-06
BRPI0710473A2 (pt) 2011-08-16
ECSP088700A (es) 2008-09-29
CA2642921A1 (en) 2007-08-30
NO20083708L (no) 2008-09-23
AR059621A1 (es) 2008-04-16
AU2007217575A1 (en) 2007-08-30
US20070203210A1 (en) 2007-08-30
MX2008010884A (es) 2008-09-03
KR20080090550A (ko) 2008-10-08
KR101060539B1 (ko) 2011-08-30
RU2008138163A (ru) 2010-04-10
TW200745097A (en) 2007-12-16
WO2007096315A1 (en) 2007-08-30
CR10206A (es) 2008-09-22

Similar Documents

Publication Publication Date Title
ZA200807074B (en) 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
HRP20181823T1 (hr) Aminokiselinski lipidi i njihove primjene
VN26427A1 (en) 1-substituted pyridyl-pyrazol acid amide compounds and use thereof
IL213747A0 (en) Fatty acid amide hydrolase inhibitor compounds, compositions comprising the same and uses thereof
SI2120921T1 (sl) Uporaba aminolevulinske kisline in njenih derivatov
ZA200907414B (en) Substituted Benzoylamino-indan-2-carboxylic acids and related compounds
IL195313A0 (en) Substituted beta-phenyl-alpha-hydroxy propanoic acid synthesis method and use thereof
IL210246A0 (en) Carboxylic acid compounds and pharmaceutical containing the same
HUE039199T2 (hu) Glutaminsav heterodimerjei
GB2441727B (en) Corrosion inhibitor for acids
IL196143A0 (en) Thiophene-sulfonic acid picolyl amides
IL191819A0 (en) Inhibitors of fatty acid amide hydrolase
ZA201106665B (en) Products comprising n-phenylpropenoyl amino acid amides and uses thereof
IL185248A0 (en) Amide derivatives of hyaluronic acid in osteoarthrosis
ZA200805473B (en) Inhibitors of fatty acid amide hydrolase
IL212050A (en) Bigvanides as intestinal and bile acids as peptide breakdown inhibitors by intestinal proteases
ZA200710874B (en) Thiazole carboxylic acid anilides
IL190877A0 (en) Process for the preparation of pyridylcarboxylic amides and esters
ZA201102521B (en) Radiolabelled inhibitors of the glycine 1 transporter
IL208372A0 (en) Fatty acid amides and uses thereof
PL380704A1 (pl) Sposób rozdziału diastereoizomerów Z i E estru kwasu 3-fenyloglicydowego
IL216710A0 (en) Amino acid lipids and uses thereof
PL380043A1 (pl) Sposób wytwarzania estrów kwasów 1-alkiloksykarbonyloamino-1-arylometylofosfonowych